Featured
September PBS listings climb to eight
Six pharmas have expanded their drugs on the PBS this month - including the first biologic added to the scheme for adults with uncontrolled COPD - with two companies scoring a double win
Featured
CSL lowers prices in Trump MFN deal
CSL and eight other pharmas have signed a Most Favoured Nation deal with the US, with the Aussie giant saying it does not anticipate any 'material impact' during fiscal year 2027
Industry & Companies
$10M for Aussie infectious diseases innovation
Six Australian companies addressing significant local and global unmet health needs in infectious diseases are getting support to break into commercial success
Industry & Companies
Who has the most effective MSLs, and why?
A survey of US oncologists has revealed what separates highly effective MSL teams from average ones and without prompting, doctors named the companies that stand out
Industry & Companies
Pharma deal to ramp up retail reach in Australia
New commercial collaboration bringing together 'complementary strengths' of two pharmas is a stepping-stone to further collaboration across a broad pipeline
Regulatory & Reimbursement
CEO raises red flag on PBS transparency
Boss warns there is currently no mechanism to disclose a drug’s commercial history citing the example of a treatment originally developed by Big Tobacco
Featured
World's biggest drug wins broad PBS listing
After a gruelling decade-long battle, a milestone PBS listing will see this oncology blockbuster made available to thousands of Australians living with certain advanced and metastatic cancers, including rare cancers
Industry & Companies
Patients choosing between meds or meals
The Leukaemia Foundation has launched a campaign to improve financial assistance to people diagnosed with blood cancer, so people don't need to forgo treatment due to lack of funds
Regulatory & Reimbursement
TGA reins in breast cancer label
Australia's regulator has narrowed the patient population eligible for a breast cancer drug, after initially granting approval for a broader population than other major jurisdictions
Industry & Companies
Global boss: Why strong science isn't enough
Visting Australia this week to join a discussion about the need for policy and access to keep pace with innovation and scientific ambition
Regulatory & Reimbursement
Who's at the PBAC's next meeting?
PBAC will consider eight submissions with three companies laying the groundwork to secure a broad PBS listing recommendation for their immunotherapies
Regulatory & Reimbursement
Company scores double PBS win
It's been quite the week for this company which announced a new General Manager on Friday and from tomorrow, two of its biggest drugs will be expanded
Latest
Spring blooms with fresh PBS listing
First-of-its-kind treatment in an area of unmet need scores a Spring PBS listing with the company's GM underlining the importance of innovative medicines for economic growth
Regulatory & Reimbursement
Single-pill triple therapy wins TGA tick
The TGA has approved a new single-pill triple therapy for hypertension as Johnson & Johnson and Dr Falk Pharma expand their franchises
Leadership & People
Company names new Aussie Country Leader
Almost six months after the departure of its General Manager, this company has recruited the leader of a rival pharma as its next Aussie boss
Industry & Companies
King Kong of drugs a revenue booster
While debate over public funding of weight loss drugs continues, Sigma has reported "above the norm" sales growth driven by GLP-1s
Industry & Companies
Who's been crowned an Aussie Best Workplace?
Twelve health sector organisations, including three pharmas, have made the exclusive Best Workplaces in Australia 2026 list
Leadership & People
ANZ GM lifts the lid on best workplace culture
Sandoz ANZ General Manager, Clint Holland, has pulled back the curtain on what makes the biosimilar & generics giant one of Australia’s Best Workplaces
Jobs
Regulation & Legal
Double recognition for Aussie IP strategist
The head of a boutique law firm specialising in intellectual property relating to life sciences has been tapped as a top IP practitioner globally in two categories
Latest
Aussie patients name industry's best
At a gala ceremony in Melbourne last night, the Patients Choice Awards named those making a meaningful difference to the lives of patients
Industry & Companies
Which pharma nets $1.4M... every 20 minutes?
An analysis of the world's top 200 companies reveals three pharmas are raking in seven-figures in net profit in under half an hour. Find out how fast your company makes US$1M
Jobs & Workplace
Long-timers jump to new companies
After more than a decade with the same company, these executives are moving on. Find out the latest appointments across industry
- Industry & Companies The pharma influencer adding emotion to data
- Regulatory & Reimbursement Calls for PBS co-payment freeze
- Jobs & Workplace Salary rift emerges across pharma
- Jobs & Workplace Who will survive the next pharma downsize?
- Industry & Companies Aussie jobs to go after trial failure
- Leadership & People How Dolly quietly reshaped pharma
- Regulatory & Reimbursement First treatment funded through new pathway
- Industry & Companies Aussies team up with Japanese giant
- Regulatory & Reimbursement PBAC July meeting winners and losers
- Regulatory & Reimbursement PBAC says no to higher price for blockbuster
